Free Trial

HUTCHMED (HCM) Competitors

HUTCHMED logo
GBX 212 +5.00 (+2.42%)
As of 04/17/2025 11:50 AM Eastern

HCM vs. SOPH, ITH, GRI, INDV, SLS, ERGO, SLN, BMY, AMYT, and OGN

Should you be buying HUTCHMED stock or one of its competitors? The main competitors of HUTCHMED include Sophos Group plc (SOPH.L) (SOPH), Ithaca Energy (ITH), Grainger (GRI), Indivior (INDV), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Silence Therapeutics (SLN), Bloomsbury Publishing (BMY), Amryt Pharma (AMYT), and Origin Enterprises (OGN). These companies are all part of the "pharmaceutical products" industry.

HUTCHMED vs.

Sophos Group plc (SOPH.L) (LON:SOPH) and HUTCHMED (LON:HCM) are both mid-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, community ranking, profitability and media sentiment.

36.5% of HUTCHMED shares are owned by institutional investors. 39.0% of HUTCHMED shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Sophos Group plc (SOPH.L) has a net margin of 0.00% compared to HUTCHMED's net margin of -6.87%. Sophos Group plc (SOPH.L)'s return on equity of 0.00% beat HUTCHMED's return on equity.

Company Net Margins Return on Equity Return on Assets
Sophos Group plc (SOPH.L)N/A N/A N/A
HUTCHMED -6.87%-5.71%-5.90%

Sophos Group plc (SOPH.L) received 221 more outperform votes than HUTCHMED when rated by MarketBeat users. Likewise, 80.19% of users gave Sophos Group plc (SOPH.L) an outperform vote while only 78.40% of users gave HUTCHMED an outperform vote.

CompanyUnderperformOutperform
Sophos Group plc (SOPH.L)Outperform Votes
417
80.19%
Underperform Votes
103
19.81%
HUTCHMEDOutperform Votes
196
78.40%
Underperform Votes
54
21.60%

Sophos Group plc (SOPH.L) has higher earnings, but lower revenue than HUTCHMED. HUTCHMED is trading at a lower price-to-earnings ratio than Sophos Group plc (SOPH.L), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sophos Group plc (SOPH.L)£726.90M0.00N/A£1.70N/A
HUTCHMED£771.01M2.99-£52.98M-£3.92-54.11

In the previous week, HUTCHMED had 1 more articles in the media than Sophos Group plc (SOPH.L). MarketBeat recorded 1 mentions for HUTCHMED and 0 mentions for Sophos Group plc (SOPH.L). HUTCHMED's average media sentiment score of 0.34 beat Sophos Group plc (SOPH.L)'s score of 0.00 indicating that HUTCHMED is being referred to more favorably in the news media.

Company Overall Sentiment
Sophos Group plc (SOPH.L) Neutral
HUTCHMED Neutral

Summary

Sophos Group plc (SOPH.L) beats HUTCHMED on 7 of the 12 factors compared between the two stocks.

Get HUTCHMED News Delivered to You Automatically

Sign up to receive the latest news and ratings for HCM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HCM vs. The Competition

MetricHUTCHMEDDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£2.30B£2.13B£5.30B£2.48B
Dividend Yield4.63%2.92%5.12%4.96%
P/E Ratio-54.114.3321.86129.75
Price / Sales2.99476.52380.54232,042.22
Price / Cash2.4910.2538.2628.07
Price / Book2.426.066.454.43
Net Income-£52.98M£20.70B£3.22B£5.83B
7 Day Performance1.92%1.55%2.85%3.01%
1 Month Performance-7.42%-2.43%-8.67%-1.06%
1 Year Performance-21.77%93.76%11.46%102.51%

HUTCHMED Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HCM
HUTCHMED
N/AGBX 212
+2.4%
N/A-21.5%£2.30B£771.01M-54.111,760Gap Up
SOPH
Sophos Group plc (SOPH.L)
N/AN/AN/AN/A£2.99B£726.90M341.41520
ITH
Ithaca Energy
N/AGBX 140
-0.4%
N/A+18.4%£2.92B£3.55B15.99220Positive News
High Trading Volume
GRI
Grainger
2.9263 of 5 stars
GBX 211
+3.2%
GBX 317.50
+50.5%
-15.6%£1.56B£276.05M-1,406.67372Dividend Increase
INDV
Indivior
1.9874 of 5 stars
GBX 685.50
-1.4%
GBX 1,650
+140.7%
-55.6%£1.07B£1.40B-568.381,000Gap Up
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
BMY
Bloomsbury Publishing
2.3164 of 5 stars
GBX 579
-0.7%
GBX 825
+42.5%
+5.1%£467.21M£382.40M12.3934,300
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
OGN
Origin Enterprises
N/AGBX 3.10
+3.3%
N/A-6.7%£327.32M£183.08B8.9610,000Dividend Increase
Gap Up

Related Companies and Tools


This page (LON:HCM) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners